Schroder Investment Management Group Has $47.22 Million Holdings in McKesson Co. (NYSE:MCK)

Schroder Investment Management Group reduced its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 17.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 82,863 shares of the company's stock after selling 17,497 shares during the quarter. Schroder Investment Management Group owned approximately 0.07% of McKesson worth $47,224,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MCK. Norges Bank purchased a new stake in shares of McKesson during the fourth quarter worth $1,200,361,000. Janus Henderson Group PLC raised its stake in shares of McKesson by 126.8% during the 3rd quarter. Janus Henderson Group PLC now owns 574,440 shares of the company's stock worth $283,903,000 after purchasing an additional 321,119 shares in the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of McKesson during the 4th quarter worth about $178,397,000. Raymond James Financial Inc. acquired a new stake in shares of McKesson during the 4th quarter valued at about $128,125,000. Finally, Boston Partners grew its stake in shares of McKesson by 24.6% in the 4th quarter. Boston Partners now owns 1,096,301 shares of the company's stock valued at $625,501,000 after buying an additional 216,432 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the stock. Citigroup reduced their target price on shares of McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a research note on Friday, January 10th. Wells Fargo & Company upped their price objective on shares of McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a report on Friday, March 14th. Evercore ISI raised their target price on McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a report on Thursday, February 6th. Morgan Stanley boosted their price target on McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research report on Wednesday. Finally, StockNews.com lowered McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Two equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $661.00.

Remove Ads

McKesson Trading Up 3.3 %

MCK traded up $23.18 on Thursday, hitting $716.71. 2,211,539 shares of the stock traded hands, compared to its average volume of 846,308. The business has a fifty day moving average price of $629.16 and a two-hundred day moving average price of $582.85. The firm has a market capitalization of $89.82 billion, a PE ratio of 32.82, a P/E/G ratio of 1.29 and a beta of 0.52. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $733.50.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, equities research analysts forecast that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd were given a dividend of $0.71 per share. The ex-dividend date was Monday, March 3rd. This represents a $2.84 annualized dividend and a dividend yield of 0.40%. McKesson's dividend payout ratio (DPR) is currently 13.00%.

Insider Activity at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of McKesson stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. The trade was a 12.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Leann B. Smith sold 188 shares of the stock in a transaction that occurred on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the completion of the transaction, the executive vice president now directly owns 1,051 shares of the company's stock, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 18,110 shares of company stock valued at $10,855,706 over the last quarter. 0.11% of the stock is owned by company insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.